Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009217
Chunk: 92

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 92
---
 (B) | any action including any action commenced by a member of the Company in its own                                                              
 name or on behalf of the Company, asserting a claim of breach of any fiduciary or other duty owed by any director, officer or other employee 
 of the Company (including but not limited to duties arising under the Act); or                                                               |

| (C) | an action arising out of or in connection with these Articles (pursuant to any provision of the laws of                                      
 England and Wales or the Company's memorandum of association and Articles (as either may be may be amended from time to time)), or otherwise 
 in any way relating to the constitution or conduct of the Company.                                                                           |

| 147.2 | Unless the Company consents in writing to the selection of an alternative forum, the federal district                                 
 courts of the United States of America shall be the sole and exclusive forum for the resolution of any complaint asserting a cause of 
 action arising under the United States Securities Act of 1933, as amended or any successor thereto.                                   |

| 73 |

| 147.3 | For the avoidance of doubt, nothing contained in this Article 146 shall apply to any action brought to                              
 enforce a duty or liability created by the United States Securities Exchange Act of 1934 Act, as amended, or any successor thereto. |

<div align='center'>74</div>